Dd of thyroditis

Reading File
Finding Sources
Searching PubMed

thyroiditis differential diagnosis classification

Reading File
Reading File
Reading File
Reading File
Reading File
I have enough comprehensive material now. Let me compile the full differential diagnosis of thyroiditis.

Differential Diagnosis of Thyroiditis

Thyroiditis encompasses a diverse group of disorders characterized by thyroid inflammation. The key clinical discriminators are: pain, thyroid function (hyper/hypo/eu), radioactive iodine uptake (RAIU), antibody profile, and chronicity.

Overview Table

TypePainFunctionRAIUAntibodiesCourse
HashimotoNoHypo (eventual)Low/normalAnti-TPO, anti-TG highChronic, permanent
De Quervain (subacute granulomatous)Yes (severe)Hyper → Hypo → EuthyroidVery lowNegative (transient ESR rise)Self-limited weeks-months
Silent/Painless (sporadic)NoHyper → Hypo → EuthyroidVery lowAnti-TPO positive (moderate)Self-limited
PostpartumNoHyper → Hypo → EuthyroidVery lowAnti-TPO positiveSelf-limited; may recur
Riedel (sclerosing)No (hard, woody)Usually HypoLowVariableChronic, progressive fibrosis
Suppurative (acute bacterial)Yes (severe, focal)Usually EuthyroidNormalNegativeAcute, responds to antibiotics
Drug-inducedNo (usually)Hyper or HypoLowVariableDepends on drug

1. Hashimoto Thyroiditis (Chronic Autoimmune Thyroiditis)

  • Most common cause of hypothyroidism in iodine-sufficient areas
  • Female predominance 10:1 to 20:1; peak age 45-65 years
  • Pathogenesis: Breakdown of self-tolerance to thyroid autoantigens; CD8+ cytotoxic T cells, Th1 cytokines (IFN-gamma), and anti-TPO/anti-thyroglobulin antibodies all contribute to follicular destruction
  • Genetics: CTLA4, PTPN22, IL2RA polymorphisms increase susceptibility
  • Morphology: Diffusely enlarged pale firm gland; lymphoplasmacytic infiltrate + germinal centers; oncocytic (Hurthle cell) metaplasia of follicular epithelium; variable fibrosis
  • Labs: Anti-TPO and anti-thyroglobulin antibodies elevated in >90%; eventually high TSH, low free T4
  • Clinical: Goiter (initially), then gradual gland atrophy; associated with other autoimmune conditions (T1DM, vitiligo, pernicious anemia, Sjogren's)
  • Complications: Small increased risk of B-cell lymphoma of the thyroid; possible progression to hypothyroid crisis
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 998-999

2. Subacute Granulomatous Thyroiditis (De Quervain Thyroiditis / Painful Thyroiditis)

  • Probably viral in origin (preceded by upper respiratory infection - Coxsackie, mumps, influenza, adenovirus)
  • More common in females; peak age 30-50 years
  • Triphasic course:
    1. Thyrotoxic phase (1-3 months): released preformed hormone
    2. Hypothyroid phase: depleted stores
    3. Recovery to euthyroidism (in most patients)
  • Key feature: PAINFUL thyroid - severe neck pain often radiating to jaw/ear, may be systemic (fever, malaise)
  • Labs: Very low RAIU (hallmark), elevated ESR (often >50 mm/hr), elevated free T4/T3, suppressed TSH; anti-TPO usually absent or low
  • Morphology: Granulomatous inflammation with foreign-body giant cells engulfing colloid
  • Treatment: NSAIDs for pain; corticosteroids if severe; beta-blockers for symptoms; thyroxine replacement if hypothyroid phase prolonged
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 999-1000

3. Silent (Painless) Thyroiditis and Postpartum Thyroiditis

  • Autoimmune variants - essentially the same disease; postpartum thyroiditis is silent thyroiditis occurring within 12 months of delivery
  • Postpartum incidence ~10% of pregnancies; higher risk with anti-TPO positivity in first trimester
  • Clinical: PAINLESS goiter; same triphasic hyper → hypo → recovery pattern as de Quervain, but milder
  • ~25% experience only thyrotoxic phase; ~50% experience only hypothyroid phase
  • Labs: Low RAIU during toxic phase (T3:T4 ratio <20, unlike Graves where T3 preferentially elevated); anti-TPO positive; TSH receptor antibodies NEGATIVE (distinguishes from Graves)
  • Doppler ultrasound: Markedly decreased flow (vs. increased flow in Graves)
  • Prognosis: ~25% develop permanent hypothyroidism; recurrence in subsequent pregnancies is common
  • Goldman-Cecil Medicine, p. 2440

4. Riedel (Sclerosing) Thyroiditis

  • Rare - accounts for ~1 in 100,000 thyroid surgeries
  • Often associated with IgG4-related disease (can involve salivary/lacrimal glands, bile ducts, retroperitoneum, mediastinum)
  • Clinical: Painless, rock-hard "woody" goiter; may compress trachea/esophagus causing dysphagia, stridor; may invade surrounding structures (unlike carcinoma, it is benign but fibrotic)
  • Labs: Usually hypothyroid; elevated IgG4 levels in associated cases
  • Distinguished from anaplastic carcinoma by biopsy showing dense fibrosis without malignant cells
  • Treatment: Tamoxifen, corticosteroids; surgical decompression if trachea compromised
  • Goldman-Cecil Medicine, p. 2441

5. Acute Suppurative (Infectious) Thyroiditis

  • Rare - bacterial (Staph. aureus, Strep., anaerobes), fungal, or parasitic
  • Predisposing factors: immunocompromised state, piriform sinus fistula (in children), preexisting thyroid disease
  • Clinical: Acute onset severe pain, fever, tenderness, fluctuance; surrounding erythema; thyroid usually euthyroid
  • Diagnosis: FNA with Gram stain and culture; ultrasound shows abscess
  • Treatment: IV antibiotics + surgical drainage

6. Drug-Induced Thyroiditis

Major offenders:
DrugMechanismPattern
AmiodaroneExcess iodine (type 1 = iodine-mediated) or direct cytotoxicity (type 2 = destructive)Hyper or hypo
LithiumInhibits thyroid hormone releaseHypothyroidism
Immune checkpoint inhibitors (nivolumab, pembrolizumab)Autoimmune activationPainless thyroiditis; hyper then hypo (often permanent)
Interferon-alphaTriggers autoimmune thyroiditisHyper or hypo
Tyrosine kinase inhibitors (sunitinib, sorafenib)Direct cytotoxicityUsually hypothyroid
  • Key point: even a single dose of an immune checkpoint inhibitor can trigger autoimmune thyroid dysfunction
  • Amiodarone-induced thyrotoxicosis is the hardest to treat; if type 1 vs type 2 cannot be distinguished, treat both simultaneously (methimazole + prednisone)
  • Goldman-Cecil Medicine, p. 2440-2441

Key Distinguishing Points for Boards/Clinic

FindingGravesHashimotoDe QuervainSilent/PostpartumRiedel
PainNoNoYESNoNo (but hard)
RAIUHIGHLow-normalVery LOWVery LOWLow
TSH-R Ab (TRAb)PositiveNegativeNegativeNegativeNegative
Anti-TPOPositive (~75%)Positive (>90%)Usually negativePositiveVariable
ESRNormalNormalVery HIGHNormalNormal
ExophthalmosPossibleNoNoNoNo
Doppler flowIncreasedNormalDecreasedDecreasedDecreased

Sources:
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, pp. 998-1000
  • Robbins & Kumar Basic Pathology, pp. 998-999
  • Goldman-Cecil Medicine (International Edition), pp. 2440-2441
This is a shared conversation. Sign in to Orris to start your own chat.